Assertio Therapeutics, Inc. Recorded Big Gain
Fri, Nov 05, 2021 at 05:30 PM
Assertio Therapeutics, Inc. (ASRT:NASDAQ) rocketted at $1.52, a gain of 36.9%. On Thu, Nov 04, 2021, ASRT:NASDAQ hit a New 2-Week Intraday High of $1.15. The stock appeared on our News Catalysts scanner on Thu, Nov 04, 2021 at 04:53 PM in the 'EARNINGS' category. From Thu, Oct 21, 2021, the stock recorded 50.00% Up Days and 54.55% Green Days
The share price of the company has been moving sideways in recent weeks.
About Assertio Therapeutics, Inc. (ASRT:NASDAQ)
Depomed Inc is a specialty pharmaceutical company focused on pain and other conditions and diseases of the central nervous system.
Top 10 Gainers:
- Assertio Therapeutics, Inc. (ASRT:NASDAQ), 36.94%
- KDNY (KDNY:NASDAQ), 30.39%
- BIGC (BIGC:NASDAQ), 28.27%
- CFLT (CFLT:NASDAQ), 27.17%
- Grid Dynamics Holdings, Inc. (GDYN:NASDAQ), 26.68%
- Alimera Sciences, Inc. (ALIM:NASDAQ), 26.67%
- ALZN (ALZN:NASDAQ), 25.76%
- ReWalk Robotics Ltd. (RWLK:NASDAQ), 25.58%
- Revlon, Inc. (REV:NYSE), 25.11%
- Endo International plc (ENDP:NASDAQ), 25.1%